Ultrasound Elastography Correlates Treatment Response by Antiviral Therapy in Patients with Chronic Hepatitis C

被引:17
|
作者
Yada, Norihisa [1 ]
Sakurai, Toshiharu [1 ]
Minami, Tomohiro [1 ]
Arizumi, Tadaaki [1 ]
Takita, Masahiro [1 ]
Inoue, Tatsuo [1 ]
Hagiwara, Satoru [1 ]
Ueshima, Kazuomi [1 ]
Nishida, Naoshi [1 ]
Kudo, Masatoshi [1 ]
机构
[1] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 5898511, Japan
关键词
Antiviral therapy; Liver stiffness; Liver fibrosis; Liver fibrosis index; Strain elastography; TRANSIENT ELASTOGRAPHY; LIVER STIFFNESS; HEPATOCELLULAR-CARCINOMA; INTERFERON THERAPY; EFSUMB GUIDELINES; VIRAL-HEPATITIS; RISK-ASSESSMENT; CLINICAL-USE; FIBROSIS; RECOMMENDATIONS;
D O I
10.1159/000368155
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To investigate the relationship between tissue elasticity before and after antiviral therapy and shear wave as well as strain elastography. Methods: FibroScan and real-time tissue elastography were performed before and after antiviral therapy for chronic hepatitis C, and treatment efficacy and elastographic findings were comparatively analyzed. Elasticity was evaluated by measuring liver stiffness (LS) in kilopascals using FibroScan, and the liver fibrosis index (LFI) was assessed by real-time tissue elastography. Results: LS and LFI correlated well before and after therapy (r = 0.567, p = 0.003 and r = 0.576, p = 0.002, respectively). In the group without a sustained virological response (SVR), LS increased in 4 of 5 patients. Patients with an increase in both LS and LFI were all in the non-SVR group (3/3, 100%). In addition, LS increased in all patients except 1 in the non-SVR group (4/5, 80%). In the SVR group, both LS and LFI decreased in all patients except 1 (18/19, 94.7%). In the patient with an increase in LS despite achieving SVR, LS decreased quickly after alcohol cessation. Conclusions: With a few exceptions, SVR improved LS. All patients with an increase in LFI were in the non-SVR group, even though LFI decreased in 2 patients. Our findings suggest that an LFI increase indicates lack of treatment efficacy with antiviral therapy. LFI may be useful for the assessment of treatment efficacy in patients with worsening of LS despite achieving SVR with antiviral therapy. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:118 / 123
页数:6
相关论文
共 50 条
  • [31] Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C
    Harrison, SA
    Brunt, EM
    Qazi, RA
    Oliveri, DA
    Neuschwander-Tetri, BA
    Di Bisceglie, AM
    Bacon, BR
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2005, 3 (06) : 604 - 609
  • [32] Modulation of cytokine response in chronic hepatitis C (chc) patients treated with combination antiviral therapy
    Trapero, M
    Moreno-Monteagudo, JA
    Vitón, M
    Muñoz, C
    Borque, MJ
    Garcia-Buey, L
    Salcedo-Mora, X
    Moreno-Otero, R
    GASTROENTEROLOGY, 2005, 128 (04) : A724 - A724
  • [33] Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C
    Rosen, HR
    McHutchison, JG
    Conrad, AJ
    Lentz, JJ
    Marousek, G
    Rose, SL
    Zaman, A
    Taylor, K
    Chou, SW
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (03): : 714 - 720
  • [34] Hepatitis C virus genome complexity correlates with response to interferon therapy: A study in French patients with chronic hepatitis C
    LeGuen, B
    Squadrito, G
    Nalpas, B
    Berthelot, P
    Pol, S
    Brechot, C
    HEPATOLOGY, 1997, 25 (05) : 1250 - 1254
  • [35] Antiviral therapy for treatment naive patients with hepatitis C virus
    Oh, S
    Afdhal, NH
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2006, 20 (01) : 99 - +
  • [36] Antiviral therapy for treatment naive patients with hepatitis C virus
    Oh, S
    Afdhal, NH
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (03) : 497 - +
  • [37] Mechanisms of non-response to antiviral treatment in chronic hepatitis C
    Chevaliez, Stephane
    Asselah, Tarik
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2011, 35 : S31 - S41
  • [38] Antiviral therapy in patients with chronic hepatitis C related hepatocellular carcinoma responding to palliative treatment
    Lee, J. I.
    Lee, K. S.
    Kim, J. K.
    Yoo, J. H.
    Chang, H. Y.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S531 - S531
  • [39] The efficiency of antiviral therapy in patients with chronic hepatitis C infected with hepatitis C virus recombinants
    Yushchuk, N. D.
    Znoyko, O. O.
    Dudina, K. R.
    Kozina, A. N.
    Kalinina, O. V.
    TERAPEVTICHESKII ARKHIV, 2016, 88 (06): : 101 - 105
  • [40] Exploring lipid and apolipoprotein levels in chronic hepatitis C patients according to their response to antiviral treatment
    Lacerda, Gilmar de Souza
    Medeiros, Thalia
    do Rosario, Natalia Fonseca
    Saramago Peralta, Regina Helena
    Cabral-Castro, Mauro Jorge
    Cathala Esberard, Eliane Bordalo
    de Andrade, Thais Guarana
    Xavier, Analucia Rampazzo
    Silva, Andrea Alice
    CLINICAL BIOCHEMISTRY, 2018, 60 : 17 - 23